Overview

Corporate Profile

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. This industry depends on a broad range of tests, known as "bioassays," to discover new drugs, identify new genes or simply monitor blood cholesterol levels. The in-house experts at Luminex have developed an innovative approach to bioassays, known as xMAP® technology. This groundbreaking technology enables companies and laboratories to ... More >>

Shareholder Information
LMNX (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$23.67
Change (%) Stock is Down 0.15 (0.63%)
Volume115,400
Data as of 05/16/12 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
04/30/12Luminex Corporation Reports First Quarter 2012 Results
Revenue Growth of 13 percent over prior year AUSTIN, Texas, April 30, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results fo... 
Printer Friendly Version
04/26/12Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform
xMAP® NeoPlex4® Assay and Automated System Set New Standard in Neonatal Care AUSTIN, Texas, April 26, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today t... 
Printer Friendly Version
04/24/12Luminex Corporation Expands Life Science and Biodefense Groups
Two Dedicated Groups Advance Luminex Leadership in Scientific Research and Public Safety AUSTIN, Texas, April 24, 2012 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMN... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
Download Documentation 2011 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Luminex Corp posts new information to the site. Just enter your e-mail address and click Submit.
 
Transfer Agent
Mellon Investor Services LLC
480 Washington Blvd.
Jersey City, NJ 07310
Phone: (866) 894-3619
Corporate Website: http://www.melloninvestor.com/newMISWeb/index.asp

For Investor Relations questions, please email investor@luminexcorp.com
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.